Dose and fractionation concepts in the primary radiotherapy of non-small cell lung cancer

M Baumann, S Appold, C Petersen, D Zips… - Lung cancer, 2001 - Elsevier
At present, radiotherapy alone or in combination with chemotherapy offers the only chance
of cure of medically inoperable or locally advanced unresectable non-small cell lung cancer …

Review of the curative role of radiotherapy in the treatment of non-small cell lung cancer

L Damstrup, HS Poulsen - Lung Cancer, 1994 - Elsevier
The present paper is a comprehensive review of available data concerning the role of
radiotherapy as an intended curative treatment in patients with non-small cell lung cancer …

Hypofractionated radiation therapy in unresectable stage iii non‐small cell lung cancer

BJ Slotman, KH Njo, A De Jonge, OWM Meijer… - Cancer, 1993 - Wiley Online Library
Background. Hypofractionation is the current choice for radiation therapy for patients with
unresectable non‐small cell lung cancer (NSCLC) at the authors' institute. Methods. In this …

Non-small cell lung cancer: Role of radiation therapy

JD Cox - Chest, 1986 - Elsevier
The most important role of radiation therapy for carcinoma of the lung is its contribution to
cure. Important technical advances in radiation therapy have been made that, along with …

[HTML][HTML] Dose and fractionation in radiation therapy of curative intent for non-small cell lung cancer: meta-analysis of randomized trials

J Ramroth, DJ Cutter, SC Darby, GS Higgins… - International Journal of …, 2016 - Elsevier
Purpose The optimum dose and fractionation in radiation therapy of curative intent for non-
small cell lung cancer remains uncertain. We undertook a published data meta-analysis of …

The evolving role of radiation therapy in the treatment of locally advanced lung cancer.

MB Hazuka, AT Turrisi 3rd - Seminars in oncology, 1993 - europepmc.org
RT has been used routinely in the treatment of NSCLC and SCLC for the past several
decades. Although largely considered a palliative treatment by most oncologists, there is …

Radiotherapy alone in technically operable, medically inoperable, early-stage (I/II) non-small-cell lung cancer

B Jeremic, J Classen, M Bamberg - International Journal of Radiation …, 2002 - Elsevier
Purpose: To investigate the effectiveness of high-dose, curative radiotherapy (RT) given
alone in technically operable, but medically inoperable, patients with early-stage (I–II) non …

Routine use of continuous, hyperfractionated, accelerated radiotherapy for non–small-cell lung cancer: A five-center experience

OS Din, J Lester, A Cameron, J Ironside, A Gee… - International Journal of …, 2008 - Elsevier
PURPOSE: To report the results from continuous, hyperfractionated, accelerated
radiotherapy (CHART) used as the standard fractionation for radical RT in the management …

73.6 Gy and beyond: Hyperfractionated, accelerated radiotherapy for non–small-cell lung cancer

PD Maguire, LB Marks, GS Sibley… - Journal of clinical …, 2001 - ascopubs.org
PURPOSE: To assess results with twice-daily high-dose radiotherapy (RT) for non–small-
cell lung cancer (NSCLC). PATIENTS AND METHODS: Between 1991 and 1998, 94 …

[HTML][HTML] Dose and fractionation schedules in radiotherapy for non-small cell lung cancer

L Kepka, J Socha - Translational Lung Cancer Research, 2021 - ncbi.nlm.nih.gov
In the field of radiotherapy (RT), the issues of total dose, fractionation, and overall treatment
time for non-small cell lung cancer (NSCLC) have been extensively investigated. There is …